Skip to main content
NCBI home page
Cancer Immunology, Immunotherapy : CII logoLink to Cancer Immunology, Immunotherapy : CII
. 1994 Mar;38(2):135–141. doi: 10.1007/BF01526209

Transfection of the mouse ICAM-1 gene into murine neuroblastoma enhances susceptibility to lysis, reduces in vivo tumorigenicity and decreases ICAM-2-dependent killing

Emmanuel Katsanis 1,✉, Maria A Bausero 1, Hong Xu 2, Paul J Orchard 1,3, Zhiyi Xu 1, R Scott Melvor 3,4, Adrienne A Brian 5, Bruce R Blazar 1,3
PMCID: PMC11038452  PMID: 7905790

Abstract

We determined the expression of intercellular adhesion molecules (ICAM) on neuro-2a cells in order to evaluate whether they were involved in cytolysis of murine neuroblastoma. Fluorescence-activated cell sorting analysis revealed that the control neomycin-resistance-genetransduced line (neuro-2a/LN) had poor expression of ICAM-1 (mean channel fluorescence, MCF=3.7). An ICAM-1-positive transfectant of neuro-2a (neuro-2a/ICAM-1+) (CMF=64.3) was generated to evaluate directly the role of this adhesion molecule in cytolysis. Neuro-2a/ICAM-1+ was more sensitive to LAK killing (69.7% at an effector-to-target ratio of 100∶1) compared to neuro-2a/LN (48.6%) (P<0.001). Blocking of neuro-2a/LN and neuro-2a/ICAM-1+ lysis with anti-ICAM-1 monoclonal antibodies (mAbs) did not account for all the LFA-1-dependent killing. These data indicate that even in neuro-2a/ICAM-1+ cells, other LFA-1 ligands participated in the effector-target interaction. Therefore, we examined these cell lines for ICAM-2 expression. Both neuro-2a/LN and neuro-2a/ICAM-1+ lines expressed ICAM-2 (MCF=16.4 and 16.5). ICAM-2 accounted for the majority of the LFA-1-dependent killing in the ICAM-1-negative target, neuro-2a/LN, while ICAM-1 played a primary role in the cytolysis of the ICAM-1+ transfectant. Inhibition of lysis in the presence of anti-ICAM-1 and ICAM-2 mAbs was comparable to that seen with the addition of anti-LFA-1 mAb, indicating that other LFA-1 ligands were not involved in this system. ICAM-1 expression was associated with decreased in vivo tumorigenicity; mice inoculated with neuro-2a/ICAM-1+ cells had a significantly longer survival compared to those receiving neuro-2a/LN cells (median survival time 35.5 versus 24.5 days) (P<0.001). It is important to note that ICAM-1 transfection of murine neuroblastoma did not alter its metastatic potential. We conclude that transfection of mouse neuroblastome with ICAM-1 increases its sensitivity to in vitro lysis and reduces its in vivo tumorgenicity. In ICAM-1-negative murine neuroblastoma cells, ICAM-2 plays a primary role in cell-mediated lysis.

Key words: Neuroblastoma, Cytolysis, ICAM-1, ICAM-2, Tumorigenicity

Footnotes

This work was supported in part by the Children's Cancer Research Fund, the Minnesota Medical Foundation, the Viking Children's Fund and NIH grants PO1-CA-21737, NO1-AI-85002. E. K. is a recipient of the Irvine McQuarrie Research Scholar Award and B. R. B. a recipient of the Edward Mallinkrodt Foundation Scholar Award

References

  • 1.Augusti-Tocco G, Sato G. Establishment of functional clonal lines of neurons from mouse neuroblastoma. Proc Natl Acad Sci USA. 1969;64:311–315. doi: 10.1073/pnas.64.1.311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Choi SH, Reynolds JV, Ziegler MM. Systematic analysis of the immunoregulation of murine neuroblastoma. J Pediatr Surg. 1989;24:15–20. doi: 10.1016/s0022-3468(89)80292-1. [DOI] [PubMed] [Google Scholar]
  • 3.de Fougerolles AR, Stacker SA, Schwarting R, Springer TA. Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1. J Exp Med. 1991;174:253–267. doi: 10.1084/jem.174.1.253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Dustin ML, Springer TA. Lymphocyte function-associated antigen-1 (LFA-1) interaction with intercellular adhesion molecule-1 (ICAM-1) is one of at least three mechanisms for lymphocyte adhesion to cultured endothelial cells. J Cell Biol. 1988;107:321–331. doi: 10.1083/jcb.107.1.321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Dustin ML, Springer TA. T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1. Nature. 1989;341:619–624. doi: 10.1038/341619a0. [DOI] [PubMed] [Google Scholar]
  • 6.Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA. Induction by IL-1 and interferon-γ: tissue distribution, biochemistry and function of a natural adherence molecule (ICAM-1) J Immunol. 1986;137:245–254. [PubMed] [Google Scholar]
  • 7.Favrot MC, Combaret V, Goillot E, Tabone E, Bouffet E, Dolbeau D, Bouvier R, Coze C, Michon J, Phillip T. Expression of leukocyte adhesion molecules on 66 clinical neuroblastoma specimens. Int J Cancer. 1991;48:502–510. doi: 10.1002/ijc.2910480405. [DOI] [PubMed] [Google Scholar]
  • 8.Gopas J, Itzhaky D, Segev Y, Salberg S, Trink B, Isakov N, Zisman-Rager B. Persistent measles virus infection enhances major histocompatibility complex class I expression and immunogenicity of murine neuroblastoma cells. Cancer Immunol Immunother. 1992;34:313–320. doi: 10.1007/BF01741552. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Graham FL, der Eb AJV. A new technique for the assay for infectivity of human adenovirus 5 DNA. Virology. 1973;52:456–467. doi: 10.1016/0042-6822(73)90341-3. [DOI] [PubMed] [Google Scholar]
  • 10.Grimm EA, Mazumder A, Zhang H, Rosenberg SA. Lymphokine activated killer phenomenon: lysis of natural killer-resistant fresh solid tumor cells by interleukin-2 activated autologous human peripheral blood lymphocytes. J Exp Med. 1982;155:1823–1830. doi: 10.1084/jem.155.6.1823. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Gross N, Carrel S, Beck D, Favre S. Cell adhesion molecules expression and modulation on human neuroblastoma cells. Adv Neuroblastoma Res. 1991;3:293–299. [PubMed] [Google Scholar]
  • 12.Gross N, Favre S, Beck D, Meyer M. Differentiation-related expression of adhesion molecules and receptors on human neuroblastoma tissues, cell lines and variants. Int J Cancer. 1992;52:85–91. doi: 10.1002/ijc.2910520116. [DOI] [PubMed] [Google Scholar]
  • 13.Handgretinger R, Kimmig A, Lang P, Daurer B, Kuci S, Bruchelt G, Treuner J, Niethammer D. Interferon-gamma upregulates the susceptibility of human neuroblastoma cells to interleukin-2-activated natural killer cells. Nat Immun Cell Growth Regul. 1989;8:189–196. [PubMed] [Google Scholar]
  • 14.Horley KJ, Carpenito C, Baker B, Takei F. Molecular cloning of murine intercellular molecule (ICAM-1) EMBO J. 1989;8:1889–1896. doi: 10.1002/j.1460-2075.1989.tb08437.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Johnson JP, Stade BG, Holzmann B, Schwable W, Riethmuller G. De novo expression of intercellular-adhesion molecule 1 in melanoma correlates with increase risk of metastases. Proc Natl Acad Sci USA. 1989;86:641–644. doi: 10.1073/pnas.86.2.641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Katsanis E, Bausero MA, Ochoa AC, Loeffler CM, Blazar BR, Leonard AS, Anderson PM. Importance in timing of cyclophosphamide on the enhancement of interleukin-2 induced cytolysis. Cancer Immunol Immunother. 1991;34:74–78. doi: 10.1007/BF01741339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Katsanis E, Blazar BR, Bausero MA, Gunther R, Anderson PM (1994) Retroperitoneal inoculation of murine neuroblastoma cells results in a reliable model for evaluation of anti-tumor immune response. J Pediatr Surg (in press) [DOI] [PubMed]
  • 18.Kuhlman P, Moy VT, Lollo BA, Brian AA. The accessory function of murine intercellular adhesion molecule-1 in T lymphocyte activation. Contributions of adhesion and co-activation. J Immunol. 1991;146:1773–1782. [PubMed] [Google Scholar]
  • 19.Lampson LA, Fisher CA. Weak HLA and β2-microglobuling expression of neuronal cell lines can be modulated by interferon. Proc Natl Acad Sci USA. 1984;81:6476–6480. doi: 10.1073/pnas.81.20.6476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Lampson LA, Fisher CA, Whelan JP. Striking paucity of HLA-A, B, C and β2-microglobulin on human neuroblastoma cell lines. J Immunol. 1983;130:2471–2478. [PubMed] [Google Scholar]
  • 21.Main EK, Lampson LA, Hart MK, Kornbluth JK, Wilson DB. Human neuroblastoma cell lines are susceptible to lysis by natural killer cells but not cytotoxic T lymphocytes. J Immunol. 1985;135:242–246. [PubMed] [Google Scholar]
  • 22.Main EK, Monos DS, Lampson LA. IFN-treated neuroblastoma cell lines remain resistant to T cell-mediated allo-killing, and susceptible to non-MHC-restricted cytotoxicity. J Immunol. 1988;141:2943–2950. [PubMed] [Google Scholar]
  • 23.Makgoba MW, Sanders ME, Luce GEG, Gugel EA, Dustin ML, Springer TA, Shaw S. Functional evidence that intercellular adhesion molecule-1 (ICAM-1) is a ligand for LFA-1 dependent adhesion in T cell-mediated cytotoxicity. Eur J Immunol. 1988;18:637–640. doi: 10.1002/eji.1830180423. [DOI] [PubMed] [Google Scholar]
  • 24.Miller AD, Rosman GJ. Improved retroviral vectors for gene transfer and expression. Biotechniques. 1989;7:980–990. [PMC free article] [PubMed] [Google Scholar]
  • 25.Naganuma H, Kiessling R, Patarroyo M, Hansson M, Handgretinger R, Gronberg A. Increased susceptibility of IFN-γ treated neuroblastoma cells to lysis by lymphokine-activated killer cells: participation of ICAM-1 induction on target cells. Int J Cancer. 1991;47:527–532. doi: 10.1002/ijc.2910470410. [DOI] [PubMed] [Google Scholar]
  • 26.Nakamura T, Takahashi K, Fukazawa T, Kovanagi M, Yokoyama A, Kato H, Yagita H, Okumura K. Relative contribution of CD2 and LFA-1 to murine T and natural killer cell functions. J Immunol. 1990;145:3628–3634. [PubMed] [Google Scholar]
  • 27.Natali P, Nicotra MR, Cavaliere R, Bigotti A, Romano G, Temponi M, Ferrone S. Differential expression of intercellular adhesion molecule 1 in primary and metastatic melanoma lesions. Cancer Res. 1990;50:1271–1278. [PubMed] [Google Scholar]
  • 28.Olmsted B, Carlson K, Klebe R, Ruddle F, Rosenbaum J. Isolation of microtubule protein from cultured mouse neuroblastoma cells. Proc Natl Acad Sci USA. 1970;65:129–136. doi: 10.1073/pnas.65.1.129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Reynolds JV, Shou JS, Choi H, Sigal R, Ziegler MM, Daly JM. The influence of natural killer cells in neuroblastoma. Arch Surg. 1989;124:235–239. doi: 10.1001/archsurg.1989.01410020109018. [DOI] [PubMed] [Google Scholar]
  • 30.Robertson MJ, Caligiuri MA, Manley TJ, Levine H, Ritz J. Human natural killer cell adhesion molecules. Differential expression after activation and participation in cytolysis. J Immunol. 1990;145:3194–3201. [PubMed] [Google Scholar]
  • 31.Sarmiento M, Dialynas DP, Lancki DW, Wall KA, Lorber MI, Loken MR, Fitch FW. Cloned T lymphocytes and monoclonal antibodies as probes for cell surface molecules active in T-cell mediated lysis. Immunol Rev. 1982;68:135–169. doi: 10.1111/j.1600-065x.1982.tb01063.x. [DOI] [PubMed] [Google Scholar]
  • 32.Sigal RK, Reynolds JV, Markmann JF, Shou J, Evantash E, Ziegler M, Naji A, Daly J. Upregulation of MHC class I: effect on growth and LAK sensitivity of neuroblastoma. Surg Forum. 1988;39:572–575. [Google Scholar]
  • 33.Sigal RK, Lieberman MD, Reynolds JV, Shou J, Ziegler MM, Daly JM. Low dose interferon gamma renders neuroblastoma more susceptible to interleukin-2 immunotherapy. J Pediatr Surg. 1991;26:389–396. doi: 10.1016/0022-3468(91)90984-2. [DOI] [PubMed] [Google Scholar]
  • 34.Simmons D, Makgoba MW, Seed B. ICAM, an adhesion ligand of LFA-1 is homologous to the neural cell adhesion molecule NCAM. Nature. 1988;331:624–627. doi: 10.1038/331624a0. [DOI] [PubMed] [Google Scholar]
  • 35.Siu G, Hedrick SM, Brian AA. Isolation of the murine intercellular adhesion molecule 1 (ICAM-1) gene ICAM-1 enhances antigen-specific T cell activation. J Immunol. 1989;143:3813–3820. [PubMed] [Google Scholar]
  • 36.Springer TA. Adhesion receptors of the immune system. Nature. 1990;346:425–434. doi: 10.1038/346425a0. [DOI] [PubMed] [Google Scholar]
  • 37.Staunton DE, Marlin SD, Stratowa C, Dustin ML, Springer TA. Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin supergene families. Cell. 1988;52:925–933. doi: 10.1016/0092-8674(88)90434-5. [DOI] [PubMed] [Google Scholar]
  • 38.Staunton DE, Dustin ML, Springer TA. Functional cloning of ICAM-2, a cell adhesion ligand for LFA-1 homologous to ICAM-1. Nature. 1989;339:61–64. doi: 10.1038/339061a0. [DOI] [PubMed] [Google Scholar]
  • 39.Takei F. Inhibition of mixed lymphocyte response by rat monoclonal antibody to a novel murine lymphocyte activation antigen (MALA-2) J Immunol. 1985;134:1403–1407. [PubMed] [Google Scholar]
  • 40.Unkeless J. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J Exp Med. 1979;152:1048–1069. doi: 10.1084/jem.150.3.580. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Vazeux R, Hoffman PA, Tomita JK, Dickinson ES, Jasman RL, St John T, Gallatin WM. Cloning and characterization of a new intercellular adhesion molecule ICAM-R. Nature. 1992;360:485–488. doi: 10.1038/360485a0. [DOI] [PubMed] [Google Scholar]
  • 42.Watanabe Y, Kuribayashi K, Miyatake S, Nishihara K, Nakayama E, Taniyama T, Sakata T. Exogenous expression of mouse interferon γ cDNA in mouse neuroblastoma C1300 cells results in reduced tumorigenicity by augmented anti-tumor immunity. Proc Natl Acad Sci USA. 1989;86:9456–9460. doi: 10.1073/pnas.86.23.9456. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Webb DSA, Mostowski HS, Gerrard TL. Cytokine-induced enhancement of ICAM-1 expression results in increased vulnerability of tumor cells to monocyte-mediated lysis. J Immunol. 1991;146:3682–3686. [PubMed] [Google Scholar]
  • 44.Xu H, Tong IL, de Fougerolles AR, Springer TA. Isolation, characterization and expression of mouse ICAM-2 complementary and genomic DNA. J Immunol. 1992;149:2650–2655. [PubMed] [Google Scholar]
  • 45.Yagita H, Nakamura T, Karasuyama H, Okumura K. Monoclonal antibodies specific for murine CD2 reveal its presence on B as well as T cells. Proc Natl Acad Sci USA. 1989;86:645–649. doi: 10.1073/pnas.86.2.645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Zier KS, Pierson GR, Brown V. Susceptibility of human neuroblastoma cell lines to cytotoxic T lymphocyte-mediated lysis. J Neuroimmunol. 1990;28:153–160. doi: 10.1016/0165-5728(90)90029-m. [DOI] [PubMed] [Google Scholar]

Articles from Cancer Immunology, Immunotherapy : CII are provided here courtesy of Springer

RESOURCES